NHS Framework agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders. The agreement will start on 1.7.2014 to 30.6.2015 with options to extend up to a further 36 months. Please refer to Document No 05d in the ITO documents for the list of participating authorities.